{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:19:11Z","timestamp":1780399151821,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bvth.2026.100150","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:27:57Z","timestamp":1771262877000},"page":"100150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2158-0721","authenticated-orcid":false,"given":"Juha","family":"Kotimaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-6697","authenticated-orcid":false,"given":"Mikel Artero","family":"Rezola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-0650","authenticated-orcid":false,"given":"Annukka","family":"Jouppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1911-3094","authenticated-orcid":false,"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-501X","authenticated-orcid":false,"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bvth.2026.100150_bib1","first-page":"71","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.bvth.2026.100150_bib2","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.bvth.2026.100150_bib3","first-page":"81","article-title":"Platelet mediated complement activation","volume":"632","author":"Peerschke","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"14","key":"10.1016\/j.bvth.2026.100150_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100150_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-065X.2001.1800104.x","article-title":"Role of the C5b-9 complement complex in cell cycle and apoptosis","volume":"180","author":"Rus","year":"2001","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.bvth.2026.100150_bib6","doi-asserted-by":"crossref","first-page":"C951","DOI":"10.1152\/ajpcell.00252.2022","article-title":"Procoagulant platelets: novel players in thromboinflammation","volume":"323","author":"Denorme","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100150_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0034-1395157","article-title":"Mast cell-derived heparin proteoglycans as a model for a local antithrombotic","volume":"40","author":"Lassila","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.bvth.2026.100150_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2018.07.026","article-title":"Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation","volume":"169","author":"Chen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.bvth.2026.100150_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46840","article-title":"Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6B-B","volume":"8","author":"V\u00f6gtle","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bvth.2026.100150_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109318","article-title":"Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics","volume":"250","author":"Jouppila","year":"2025","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.bvth.2026.100150_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ejvs.2019.05.019","article-title":"Novel locally acting dual antiplatelet and anticoagulant (APAC) targets multiple sites of vascular injury in an experimental porcine model","volume":"58","author":"Barreiro","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.bvth.2026.100150_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00701-024-06017-x","article-title":"Pretreatment with a dual antiplatelet and anticoagulant (APAC) reduces ischemia\u2013reperfusion injury in a mouse model of temporary middle cerebral artery occlusion\u2014implications for neurovascular procedures","volume":"166","author":"Denorme","year":"2024","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.bvth.2026.100150_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118567","article-title":"Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe\u2212\/\u2212 mice","volume":"397","author":"Bot","year":"2024","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bvth.2026.100150_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/j.0959-9673.2004.390af.x","article-title":"Identification of major heparin-binding proteins in plasma using electrophoresis and mass spectrometry","volume":"85","author":"Killeen","year":"2004","journal-title":"Int J Exp Pathol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100150_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ndt\/gft243","article-title":"Heparin\/heparan sulphate interactions with complement\u2014a possible target for reduction of renal function loss?","volume":"29","author":"Zaferani","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.bvth.2026.100150_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jim.2014.06.011","article-title":"Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia\/reperfusion injury","volume":"412","author":"Kotimaa","year":"2014","journal-title":"J Immunol Methods"},{"issue":"1-2","key":"10.1016\/j.bvth.2026.100150_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J Immunol Methods"},{"issue":"12","key":"10.1016\/j.bvth.2026.100150_bib18","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20050189","article-title":"C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation","volume":"201","author":"Trouw","year":"2005","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.bvth.2026.100150_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052286","article-title":"Whole blood thromboelastometry by ROTEM and thrombin generation by Genesia according to the genotype and clinical phenotype in congenital fibrinogen disorders","volume":"22","author":"Szanto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bvth.2026.100150_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039765","article-title":"Distinction of early complement classical and lectin pathway activation via quantification of C1s\/C1-INH and MASP-1\/C1-INH complexes using novel ELISAs","volume":"13","author":"Hurler","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100150_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00757-1","article-title":"Heparin-enriched plasma proteome is significantly altered in Alzheimer\u2019s disease","volume":"19","author":"Guo","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.bvth.2026.100150_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1525-1594.2007.00386.x","article-title":"Plasma protein binding properties to immobilized heparin and heparin-albumin conjugate","volume":"31","author":"Mirow","year":"2007","journal-title":"Artif Organs"},{"issue":"4","key":"10.1016\/j.bvth.2026.100150_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jbm.820250402","article-title":"Interaction of plasma proteins with heparinized gel particles studied by high-resolution two-dimensional gel electrophoresis","volume":"25","author":"Ho","year":"1991","journal-title":"J Biomed Mater Res"},{"issue":"22","key":"10.1016\/j.bvth.2026.100150_bib24","doi-asserted-by":"crossref","first-page":"19892","DOI":"10.1074\/jbc.M111.228114","article-title":"A systems biology approach for the investigation of the heparin\/heparan sulfate interactome","volume":"286","author":"Ori","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bvth.2026.100150_bib25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00216-021-03765-y","article-title":"AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)","volume":"414","author":"Winzely","year":"2022","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"10.1016\/j.bvth.2026.100150_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10157-016-1308-2","article-title":"Dual antiplatelet and anticoagulant APAC prevents experimental ischemia\u2013reperfusion-induced acute kidney injury","volume":"21","author":"Tuuminen","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.bvth.2026.100150_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2023.04.010","article-title":"Intravenously administered APAC, a dual antiplatelet anticoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice","volume":"228","author":"Bonetti","year":"2023","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.bvth.2026.100150_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"issue":"1-2","key":"10.1016\/j.bvth.2026.100150_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0162-3109(00)80301-X","article-title":"C1q: structure, function, and receptors","volume":"49","author":"Kishore","year":"2000","journal-title":"Immunopharmacology"},{"issue":"8","key":"10.1016\/j.bvth.2026.100150_bib30","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.4049\/jimmunol.1101749","article-title":"Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance","volume":"187","author":"Roumenina","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100150_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.imlet.2010.03.012","article-title":"The non-classical functions of the classical complement pathway recognition subcomponent C1q","volume":"131","author":"Nayak","year":"2010","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.bvth.2026.100150_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.1000184","article-title":"Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain","volume":"185","author":"Garlatti","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100150_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/187152809788681038","article-title":"The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses","volume":"8","author":"Peng","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.bvth.2026.100150_bib34","doi-asserted-by":"crossref","first-page":"676662","DOI":"10.3389\/fimmu.2021.676662","article-title":"Selective binding of heparin\/heparan sulfate oligosaccharides to factor H and factor H-related proteins: therapeutic potential for C3 glomerulopathies","volume":"12","author":"Loeven","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.bvth.2026.100150_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fimmu.2014.00126","article-title":"Molecular interactions between complement factor H and its heparin and heparan sulfate ligands","volume":"5","author":"Perkins","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.bvth.2026.100150_bib36","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fimmu.2018.01607","article-title":"Self-damage caused by dysregulation of the complement alternative pathway: relevance of the factor H protein family","volume":"9","author":"S\u00e1nchez-Corral","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100150_bib37","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI65861","article-title":"Detection of complement activation using monoclonal antibodies against C3d","volume":"123","author":"Thurman","year":"2013","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.bvth.2026.100150_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0161-5890(83)90172-4","article-title":"Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b","volume":"20","author":"Maillet","year":"1983","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100150_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbagen.2005.08.003","article-title":"Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance","volume":"1726","author":"Yu","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.bvth.2026.100150_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/eji.202149259","article-title":"Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells","volume":"52","author":"van Essen","year":"2022","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100150_bib41","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1074\/jbc.M110.167825","article-title":"Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease","volume":"286","author":"Zaferani","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bvth.2026.100150_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.kint.2018.06.030","article-title":"Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease","volume":"94","author":"O\u2019Flynn","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.bvth.2026.100150_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/bbrc.1994.1008","article-title":"Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H","volume":"198","author":"Meri","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.bvth.2026.100150_bib44","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","article-title":"Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid\/polyanion binding site on factor H","volume":"87","author":"Meri","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.bvth.2026.100150_bib45","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI8621","article-title":"Predominant role for C5b-9 in renal ischemia\/reperfusion injury","volume":"105","author":"Zhou","year":"2000","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100150_bib46","article-title":"APAC treatment limits collar-induced carotid atherosclerotic plaque development in apoE-\/- mice","volume":"118","author":"Bot","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bvth.2026.100150_bib47","article-title":"Antiplatelet and anticoagulant (APAC) compound restricts thromboinflammation and maintains cardiac function following myocardial injury","volume":"8","author":"Sameen","year":"2024","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032722600015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032722600015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:20:47Z","timestamp":1779895247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295032722600015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S295032722600015X"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100150","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100150"}}